Cauldron Raises $13.25M A2 to Turn Microbes Into a Nonstop Assembly Line
SOSV portfolio company Cauldron talked to TechCrunch about their $13.25 million Series A2 round, led by Main Sequence Ventures with participation from Horizons Ventures, NGS...
Category : News & update
The 100-Year Quest for Fusion Energy with Steven Cowley, Director of PPPL
Fusion energy has long been called the “holy grail” of clean power because in theory it’s cheap, abundant, clean, and safe. Yet despite 100+ years...
🎥 Navigating the Realities of Energy Scale-Up with Dr. Barbara Burger, “Godmother of Energy Investing”
📍 Broadcast live from our SOSV NY event space in Manhattan, SOSV Deep Tech LIVE is our monthly video podcast series exploring the frontiers of...
Sequential Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing & Skin Health Ingredients
For decades, skincare has been driven by claims, trends, and trial-and-error. But what if we could actually measure how products impact the skin at the...
Cocoon Raises $15M Series A for Critical Cement Substitute
Concrete is the most widely used material on earth after water, and we’re running out of a key ingredient. Widely used cement substitutes, known as...
SOSV Deep Tech Live – Season 2, Episode 2 – Heat Beneath Our Feet: Unlocking Superhot Geothermal with Carlos Araque, CEO, Quaise Energy
One of the most promising solutions to the surging energy demand lies beneath our feet: geothermal energy. But drilling to the super hot rock many...
Valanx Biotech Raises €3M in Financing
Congrats to our SOSV portfolio company VALANX Biotech on its €3 million in new funding to advance its lead antibody-drug conjugate (ADC) program. The financing...
Q&A: Avalo, The David & Goliath of Large Genome Models
Of all the languages an AI could master, without a doubt one of the hardest and most impactful is the genetic language of life itself. ...
IndieBio is Now SOSV NY & SOSV SF, Underscoring SOSV’s Leadership in Deep Tech
In 2015, SOSV opened IndieBio San Francisco, Silicon Valley’s first biotech program that offered bio-labs as well as pre-seed investment to scientists ready to launch...
Meet Avra van der Zee, SOSV’s New General Partner
When SOSV and the New Jersey Economic Development Authority (NJEDA) announced a $50 million co-investment to build a new global headquarters for SOSV’s HAX in the...